Submission Details
| 510(k) Number | K210533 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 24, 2021 |
| Decision Date | August 20, 2021 |
| Days to Decision | 177 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K210533 is an FDA 510(k) clearance for the Inset Reverse Total Shoulder System, a Shoulder Prosthesis, Reverse Configuration (Class II — Special Controls, product code PHX), submitted by Shoulder Innovations, Inc. (Holland, US). The FDA issued a Cleared decision on August 20, 2021, 177 days after receiving the submission on February 24, 2021. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3660.
| 510(k) Number | K210533 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 24, 2021 |
| Decision Date | August 20, 2021 |
| Days to Decision | 177 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | PHX — Shoulder Prosthesis, Reverse Configuration |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3660 |
| Definition | Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint. |